ZA200505757B - Thin aqueous cataplasm material - Google Patents
Thin aqueous cataplasm material Download PDFInfo
- Publication number
- ZA200505757B ZA200505757B ZA200505757A ZA200505757A ZA200505757B ZA 200505757 B ZA200505757 B ZA 200505757B ZA 200505757 A ZA200505757 A ZA 200505757A ZA 200505757 A ZA200505757 A ZA 200505757A ZA 200505757 B ZA200505757 B ZA 200505757B
- Authority
- ZA
- South Africa
- Prior art keywords
- fiber
- soft
- prepared
- cataplasm
- support
- Prior art date
Links
- 239000000835 fiber Substances 0.000 claims description 82
- 229920003023 plastic Polymers 0.000 claims description 24
- 239000004033 plastic Substances 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000088 plastic resin Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 16
- 229920002125 Sokalan® Polymers 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 15
- 239000004584 polyacrylic acid Substances 0.000 claims description 15
- -1 polyethylene Polymers 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 9
- 239000001913 cellulose Substances 0.000 claims description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 8
- 229920001971 elastomer Polymers 0.000 claims description 8
- 239000000806 elastomer Substances 0.000 claims description 8
- 239000012790 adhesive layer Substances 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 4
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 4
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 238000010030 laminating Methods 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 235000013772 propylene glycol Nutrition 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 229920000297 Rayon Polymers 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 claims description 2
- 229960001545 hydrotalcite Drugs 0.000 claims description 2
- 229910001701 hydrotalcite Inorganic materials 0.000 claims description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 239000002964 rayon Substances 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N Trimethylene glycol Natural products OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims 1
- HGVPOWOAHALJHA-UHFFFAOYSA-N ethene;methyl prop-2-enoate Chemical compound C=C.COC(=O)C=C HGVPOWOAHALJHA-UHFFFAOYSA-N 0.000 claims 1
- 229920006225 ethylene-methyl acrylate Polymers 0.000 claims 1
- 239000005043 ethylene-methyl acrylate Substances 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 22
- 239000003814 drug Substances 0.000 description 20
- 239000002674 ointment Substances 0.000 description 17
- 239000000470 constituent Substances 0.000 description 14
- 230000003902 lesion Effects 0.000 description 13
- 238000004321 preservation Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 7
- 229960004150 aciclovir Drugs 0.000 description 7
- 229960004311 betamethasone valerate Drugs 0.000 description 7
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 208000010201 Exanthema Diseases 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008807 pathological lesion Effects 0.000 description 4
- 229920006267 polyester film Polymers 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000004753 textile Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 229960005150 glycerol Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960005294 triamcinolone Drugs 0.000 description 2
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- NSMXQKNUPPXBRG-SECBINFHSA-N (R)-lisofylline Chemical compound O=C1N(CCCC[C@H](O)C)C(=O)N(C)C2=C1N(C)C=N2 NSMXQKNUPPXBRG-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229960002842 clobetasol Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003018927 | 2003-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200505757B true ZA200505757B (en) | 2006-04-26 |
Family
ID=32820597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200505757A ZA200505757B (en) | 2003-01-28 | 2005-07-19 | Thin aqueous cataplasm material |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7988990B2 (es) |
| EP (1) | EP1591111B1 (es) |
| JP (2) | JP4610482B2 (es) |
| KR (1) | KR101134846B1 (es) |
| CN (2) | CN101239198B (es) |
| AU (1) | AU2004208596C1 (es) |
| CA (1) | CA2513595C (es) |
| ES (1) | ES2623077T3 (es) |
| NO (1) | NO340678B1 (es) |
| NZ (1) | NZ541543A (es) |
| TW (2) | TW200920326A (es) |
| WO (1) | WO2004066985A1 (es) |
| ZA (1) | ZA200505757B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7887842B2 (en) * | 2003-02-07 | 2011-02-15 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
| KR100772027B1 (ko) * | 2007-05-28 | 2007-10-31 | 자연과 숯(주) | 찜질팩용 조성물 및 이를 이용한 찜질용 팩 |
| EP2671593B1 (en) * | 2011-02-02 | 2017-06-07 | Nitto Denko Corporation | Patch preparation |
| EP3622971A1 (en) * | 2012-02-29 | 2020-03-18 | Hollister Incorporated | Buffered adhesive compositions for skin-adhering medical products |
| JP2020066592A (ja) * | 2018-10-24 | 2020-04-30 | 帝國製薬株式会社 | 水性貼付剤 |
| KR20210133235A (ko) | 2019-02-27 | 2021-11-05 | 루카스 헥터 이자드 스미스 | 통기성 반창고 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61126018A (ja) | 1984-11-21 | 1986-06-13 | Daikyo Yakuhin Kogyo Kk | 貼付材等用支持体 |
| JPH05717A (ja) | 1991-06-21 | 1993-01-08 | Nippon Steel Corp | ベルトコンベアローラおよびその摩耗検査方法 |
| JPH0643130Y2 (ja) * | 1991-06-26 | 1994-11-09 | 有限会社トーワ | 貼り薬の基材 |
| JP3581863B2 (ja) | 1992-05-07 | 2004-10-27 | 積水化学工業株式会社 | 貼付剤 |
| NZ254632A (en) * | 1992-07-27 | 1997-02-24 | Procter & Gamble | Textured laminated pad, comprising a paper layer and a synthetic fiber non-woven layer, for use in topical applications |
| JPH07138154A (ja) | 1993-06-14 | 1995-05-30 | Bando Chem Ind Ltd | 皮膚貼付薬シ−トおよび粘着シ−ト |
| JP3048794B2 (ja) | 1993-07-30 | 2000-06-05 | 日本電気株式会社 | 軌跡算出方法 |
| JP2588411Y2 (ja) * | 1993-11-19 | 1999-01-13 | 積水化学工業株式会社 | 貼付剤 |
| JPH0833673A (ja) * | 1994-03-14 | 1996-02-06 | Johnson & Johnson Kk | 救急絆創膏用粘着フィルムおよび該粘着フィルムを用いた救急絆創膏 |
| JP3708975B2 (ja) * | 1994-03-31 | 2005-10-19 | 富山化学工業株式会社 | ピロキシカム貼付剤 |
| JPH07313546A (ja) * | 1994-05-24 | 1995-12-05 | Tac Medical Kk | 吸汗性貼付剤 |
| JPH0820530A (ja) | 1994-07-04 | 1996-01-23 | Dainippon Printing Co Ltd | 貼付による経皮薬用基材 |
| JPH08119855A (ja) | 1994-10-19 | 1996-05-14 | Sekisui Chem Co Ltd | 貼付剤 |
| JP4171077B2 (ja) | 1995-03-01 | 2008-10-22 | バンドー化学株式会社 | 経皮投与薬用支持体 |
| US5814031A (en) * | 1995-03-02 | 1998-09-29 | Mooney; Mark | Structured occllusive dressings |
| JP2935343B2 (ja) * | 1996-03-04 | 1999-08-16 | 花王株式会社 | シート状パック |
| JPH1067652A (ja) | 1996-08-27 | 1998-03-10 | Sekisui Chem Co Ltd | 貼付剤用支持体及びそれを用いた貼付剤 |
| US6224899B1 (en) * | 1997-03-18 | 2001-05-01 | Kobayashi Pharmaceutical Co., Ltd. | Adhesive cooling composition and process for its preparation |
| JP3406188B2 (ja) | 1997-06-23 | 2003-05-12 | 積水化学工業株式会社 | 貼付剤 |
| JP4456679B2 (ja) * | 1998-07-10 | 2010-04-28 | 久光製薬株式会社 | ステロイド含有パップ剤及びその製造方法 |
| JP2000117917A (ja) | 1998-08-14 | 2000-04-25 | Idemitsu Petrochem Co Ltd | 積層体及び皮膚貼付材 |
| JP2000212078A (ja) * | 1999-01-18 | 2000-08-02 | Lion Corp | パップ剤 |
| JP2001122771A (ja) * | 1999-10-25 | 2001-05-08 | Lion Corp | 含水性膏体の製造方法 |
| ATE353637T1 (de) * | 2000-06-06 | 2007-03-15 | Teijin Ltd | Element zur applikation einer salbe und ein salbenpflaster, das dieses verwendet |
| JP2002145763A (ja) * | 2000-11-10 | 2002-05-22 | Lion Corp | 貼付剤 |
| JP2003012508A (ja) | 2001-06-28 | 2003-01-15 | Lion Corp | 外用貼付剤 |
| JP2003181995A (ja) * | 2001-12-13 | 2003-07-03 | Idemitsu Unitech Co Ltd | 不織布積層体および皮膚貼布材 |
-
2004
- 2004-01-26 WO PCT/JP2004/000641 patent/WO2004066985A1/ja active Application Filing
- 2004-01-26 AU AU2004208596A patent/AU2004208596C1/en not_active Ceased
- 2004-01-26 US US10/542,932 patent/US7988990B2/en not_active Expired - Fee Related
- 2004-01-26 CA CA2513595A patent/CA2513595C/en not_active Expired - Lifetime
- 2004-01-26 JP JP2005504693A patent/JP4610482B2/ja not_active Expired - Lifetime
- 2004-01-26 NZ NZ541543A patent/NZ541543A/en not_active IP Right Cessation
- 2004-01-26 CN CN200810083407XA patent/CN101239198B/zh not_active Expired - Fee Related
- 2004-01-26 CN CNB2004800029964A patent/CN100387227C/zh not_active Expired - Fee Related
- 2004-01-26 EP EP04705178.4A patent/EP1591111B1/en not_active Expired - Lifetime
- 2004-01-26 KR KR1020057013851A patent/KR101134846B1/ko active IP Right Grant
- 2004-01-26 ES ES04705178.4T patent/ES2623077T3/es not_active Expired - Lifetime
- 2004-01-28 TW TW097136102A patent/TW200920326A/zh not_active IP Right Cessation
- 2004-01-28 TW TW093101880A patent/TWI322683B/zh not_active IP Right Cessation
-
2005
- 2005-07-19 ZA ZA200505757A patent/ZA200505757B/en unknown
- 2005-08-26 NO NO20053982A patent/NO340678B1/no not_active IP Right Cessation
-
2009
- 2009-09-04 JP JP2009204427A patent/JP5292233B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1591111A4 (en) | 2010-01-13 |
| KR101134846B1 (ko) | 2012-04-13 |
| NO20053982L (no) | 2005-08-26 |
| JP5292233B2 (ja) | 2013-09-18 |
| EP1591111B1 (en) | 2017-04-05 |
| WO2004066985A1 (ja) | 2004-08-12 |
| TWI322683B (en) | 2010-04-01 |
| JPWO2004066985A1 (ja) | 2006-05-18 |
| NZ541543A (en) | 2008-02-29 |
| CA2513595C (en) | 2012-03-13 |
| EP1591111A1 (en) | 2005-11-02 |
| CN101239198A (zh) | 2008-08-13 |
| KR20050095628A (ko) | 2005-09-29 |
| CN1744885A (zh) | 2006-03-08 |
| TW200423908A (en) | 2004-11-16 |
| NO340678B1 (no) | 2017-05-29 |
| TWI362926B (es) | 2012-05-01 |
| AU2004208596A1 (en) | 2004-08-12 |
| CN100387227C (zh) | 2008-05-14 |
| AU2004208596C1 (en) | 2012-01-19 |
| US20060093654A1 (en) | 2006-05-04 |
| JP4610482B2 (ja) | 2011-01-12 |
| US7988990B2 (en) | 2011-08-02 |
| CN101239198B (zh) | 2012-03-14 |
| JP2010013470A (ja) | 2010-01-21 |
| ES2623077T3 (es) | 2017-07-10 |
| TW200920326A (en) | 2009-05-16 |
| CA2513595A1 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001295211B2 (en) | Hydrogel composition for transdermal drug delivery | |
| US20030109819A1 (en) | Adhesive preparations | |
| KR20120035220A (ko) | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 | |
| ZA200505757B (en) | Thin aqueous cataplasm material | |
| DE10212864B4 (de) | Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung | |
| KR101787801B1 (ko) | 3층구조의 지지체 및 이를 이용한 수성 패치제 | |
| EP0664119B1 (en) | Tape transdermal use easily detachable from the skin | |
| US6436433B1 (en) | Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties | |
| WO2003013482A1 (en) | Transdermal delivery of 5-ht3 antagonists | |
| KR102009547B1 (ko) | 경피 흡수 촉진제, 및 그것을 함유하는 첩부제 | |
| US7018648B2 (en) | Transdermal device for administering testosterone or one of the derivatives thereof | |
| JP2007031322A (ja) | 貼付剤 | |
| JPH05271056A (ja) | 微粉体制御型経皮投与製剤 | |
| ES2368652T3 (es) | Preparación adhesiva que contiene bisoprolol. | |
| KR101452536B1 (ko) | 수용성 활성 성분을 투여하기 위한 경피 치료 시스템 | |
| CA2287463A1 (en) | Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition | |
| JP5020554B2 (ja) | 非水系粘着剤組成物とこれを用いた貼付剤 | |
| JPH1112163A (ja) | 貼付剤 | |
| JP3548195B2 (ja) | 経皮吸収型製剤 | |
| JPS6016922A (ja) | 経皮吸収性薬物の投与方法 | |
| JPS61282313A (ja) | 酵素含有貼付剤 | |
| JP2007182417A (ja) | 経皮吸収促進剤及びそれを用いた経皮吸収製剤 | |
| JPH1149669A (ja) | 抗ウイルス剤含有テープ製剤 |